Administration Confirms Four Permanent Leaders at the FDA
The administration has named four acting officials as permanent leaders at the FDA, overseeing drugs, biologics, tobacco and AI modernization.
Health
Read Full News
How to Secure Care for a Grandson with Severe Mental Illness After You’re Gone
Practical legal and financial steps to safeguard a grandchild with severe mental illness after a caregiver dies.
Sharp Drop in Overdose Deaths After Years of Rise, But Toll Remains High
After annual U.S. overdose deaths topped 105,000, 2024 saw a marked decline; preliminary 2025 figures and international drops signal change amid ongoing challenges.
Civilian Toll Rises After U.S. Strikes Across Iran, Wedding Among Sites Hit
U.S. strikes across Iran left 18 dead and 108 wounded, with four killed and dozens injured at a wedding near the Strait of Hormuz.
Review Finds ADA Action Aimed at Conduct, Not Censoring Commentary
An internal ADA review says five-member expulsions followed conduct rules, not suppression of a Diabetes Care editorial; review sent to the board.
Updated Migraine Prevention Guidance Reflects Expanded Treatment Options
New joint guidance updates migraine prevention recommendations to reflect a broader range of therapies available since 2012.
FDA approves Mimrylo (rusfertide) as a new option for polycythemia vera
FDA clears rusfertide (Mimrylo) by Protagonist and Takeda as a weekly injection to treat polycythemia vera.
Six months in, US military families face mounting daily strains amid Iran conflict
Families of US service members report financial, childcare and emotional strains six months into the conflict with Iran.
Kennedy and Pennsylvania Governor Clash as Measles Deaths Renew Focus on Vaccine Claims
Robert F. Kennedy Jr. and Governor Josh Shapiro exchanged heated words after two unvaccinated Pennsylvanians died of measles-related causes.
Sword Health Files to Buy Headspace in Move to Add Mental-Health Services
Sword Health filed to acquire Headspace; filing sets a Sept. 14 effective date and does not disclose the deal value.